UTHR United Therapeutics Corp

$490.23 -0.41%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

United Therapeutics Corp (UTHR) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $21.0 billion. Shares last traded at $490.23, 19.5% below their 52-week high. Over the past year the stock is up 25.1%. UTHR trades at a price-to-earnings ratio of 16.04, below the Pharmaceutical Preparations median of 17.31. Net profit margin is 41.6%, above the peer median of -8.9%. Revenue grew 10.6% year over year.

Market Cap

$21.0B

Shares Out

42.9M

EPS (TTM)

$52.08

P/E Ratio

9.41

P/S Ratio

6.67

P/B Ratio

3.29

Dividend / Share

—

Dividend Yield

—

52-Week High

$609.10

52-Week Low

$375.81

Volume

25,594

Avg Vol (3m)

27,292.302

Performance

-7.19%

-5.52%

-10.42%

+1.12%

YTD

-1.26%

+25.08%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

35.60

SMA (50)

$526.74

SMA (200)

$523.37

Price vs SMA50

-6.93%

Price vs SMA200

-6.33%

ATR (14)

$13.90

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$3.2B

Net Income

$1.3B

Gross Margin

86.1%

Operating Margin

44.4%

Net Margin

41.6%

Return on Equity

20.5%

Return on Assets

18.2%

Current Ratio

5.73

Debt / Equity

0.13

Revenue Growth (YoY)

+10.6%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$13.07	2026-08-05
Q1 2026	$5.82	2026-05-06
FY 2025	$27.86	2026-02-25
Q3 2025	$20.17	2025-10-29
Q2 2026	$13.02	2026-08-05
Q1 2026	$6.63	2026-05-06

Full earnings history →

Pharmaceutical Preparations peers

UTHR vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

P/E vs peers

16.04 / 17.31 med

-7% discount

P/S vs peers

6.67 / 11.11 med

-40% discount

Net margin vs peers

41.6% / -8.9% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.